Ke Fei
Impact in
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Lung Cancer Diagnosis and Treatment 14
- Lung Cancer Treatments and Mutations 8
- Oncology 11
- Cancer Cells and Metastasis 4
- Lung Cancer Research Studies 4
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Gening Jiang (14 shared papers)Chang Chen (10 shared papers)Chenyang Dai (9 shared papers)Yijiu Ren (7 shared papers)Dong Xie (8 shared papers)Yunlang She (6 shared papers)Hui Zheng (5 shared papers)Xuefei Li (2 shared papers)
- Journals
- Oncotarget (3 papers)Journal of Clinical Oncology (3 papers)Frontiers in Oncology (2 papers)The Annals of Thoracic Surgery (2 papers)Interactive Cardiovascular and Thoracic Surgery (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Ke Fei
39 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 93
- Pulmonary and Respiratory Medicine 599
- Oncology 278
- Cancer Research 117
- Radiology, Nuclear Medicine and Imaging 118
- Pharmacology 43
Countries citing papers authored by Ke Fei
This map shows the geographic impact of Ke Fei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Fei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Fei more than expected).
Fields of papers citing papers by Ke Fei
This network shows the impact of papers produced by Ke Fei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Fei. The network helps show where Ke Fei may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke Fei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 181 | |
| 2 | 2012 | 120 | |
| 3 | 2016 | 119 | |
| 4 | 2011 | 115 | |
| 5 | 2015 | 105 | |
| 6 | 2014 | 79 | |
| 7 | 2016 | 52 | |
| 8 | 2021 | 51 | |
| 9 | 2016 | 51 | |
| 10 | 2018 | 34 | |
| 11 | 2015 | 29 | |
| 12 | 2020 | 27 | |
| 13 | 2020 | 26 | |
| 14 | 2020 | 24 | |
| 15 | 2016 | 24 | |
| 16 | 2016 | 20 | |
| 17 | 2019 | 19 | |
| 18 | 2014 | 18 | |
| 19 | 2016 | 16 | |
| 20 | 2022 | 13 |
About Ke Fei
Ke Fei is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Pathology and Forensic Medicine, having authored 42 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (14 papers), Lung Cancer Treatments and Mutations (8 papers), Cancer Cells and Metastasis (4 papers), Lung Cancer Research Studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Parasitic infections in humans and animals (3 papers), Single-cell and spatial transcriptomics (2 papers) and Parasitic Infections and Diagnostics (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (599 citations), Oncology (278 citations), Cancer Research (117 citations), Radiology, Nuclear Medicine and Imaging (118 citations) and Pharmacology (43 citations). Ke Fei has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Gening Jiang, Chang Chen, Chenyang Dai, Yijiu Ren, Dong Xie, Yunlang She, Hui Zheng, Xuefei Li, Fangyu Zhou and Huikang Xie. Their work appears in journals such as Oncotarget, Journal of Clinical Oncology, Frontiers in Oncology, The Annals of Thoracic Surgery and Interactive Cardiovascular and Thoracic Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.